Skip to main content
C

CanBas Co.,Ltd. — Investor Relations & Filings

Ticker · 4575 ISIN · JP3244570002 T Professional, scientific and technical activities
Open in API
Filings indexed 65 across all filing types
Latest filing 2023-09-26 Governance Information
Country JP Japan
Listing T 4575

About CanBas Co.,Ltd.

https://www.canbas.co.jp/

CanBas is a clinical-stage biopharmaceutical company dedicated to the research and development of novel therapeutics for cancer patients. The company focuses on drug discovery in the field of oncology, including immuno-oncology and treatments targeting the cell cycle. Its pipeline includes CBP501, a calmodulin-modulating peptide that has undergone Phase II clinical trials. CanBas leverages proprietary screening systems and core technologies to develop innovative anti-cancer agents, with a focus on creating treatments with potentially fewer side effects.

Recent filings

Filing Released Lang Actions
内部統制報告書－第24期(2023/09/25－2023/09/25)
Governance Information Classification · 1% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法). This type of report details the company's internal control framework, evaluation scope, and results regarding financial reporting. Since it is a specific regulatory filing concerning internal controls and does not fit into the other categories like 10-K (Annual Report) or AR (Audit Report), it is best classified as a Regulatory Filing (RNS).
2023-09-26 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-2 of the Financial Instruments and Exchange Act of Japan. This is a mandatory internal control certification document that accompanies the Annual Securities Report (Yuuka Shouken Houkokusho). Since it is a regulatory filing confirming the accuracy of the annual report and does not constitute the annual report itself, it falls under the general regulatory filings category. FY 2023
2023-09-26 Japanese
有価証券報告書－第24期(2022/07/01－2023/06/30)
Annual Report Classification · 1% confidence The document is a '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese Annual Securities Report required under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, business descriptions, and management analysis for the fiscal year ending June 30, 2023. This document is the primary annual financial filing for a Japanese company, which corresponds to the '10-K' category in the provided schema. FY 2023
2023-09-26 Japanese
四半期報告書－第24期第3四半期(2023/01/01－2023/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for the third quarter of the 24th fiscal period, covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial statements, management analysis, and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-05-12 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-8 of the Financial Instruments and Exchange Act of Japan. This is a mandatory regulatory filing that accompanies a quarterly report to confirm the accuracy of the financial statements. Since it is a specific regulatory filing required by law and does not constitute the quarterly report itself, nor does it fit into other specific categories like M&A or dividends, it is classified as a Regulatory Filing (RNS).
2023-05-12 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of the Second Quarter Report (Interim Report). While it references the quarterly report, the document itself is a formal regulatory filing confirming the validity of the financial statements, which falls under the category of Regulatory Filings (RNS) as it is a specific compliance document required by Japanese financial law that does not constitute the financial report itself.
2023-02-10 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.